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A B S T R A C T
Parkinsonian bradykinesia and rigidity are typically associated with excessive beta band oscillations in the
subthalamic nucleus. Recently another spectral peak has been identiﬁed that might be implicated in the pa-
thophysiology of the disease: high-frequency oscillations (HFO) within the 150–400 Hz range. Beta-HFO phase-
amplitude coupling (PAC) has been found to correlate with severity of motor impairment. However, the neu-
ronal origin of HFO and its usefulness as a potential target for deep brain stimulation remain to be established.
For example, it is unclear whether HFO arise from the same neural populations as beta oscillations. We in-
traoperatively recorded local ﬁeld potentials from the subthalamic nucleus while advancing DBS electrodes in
2 mm steps from 4 mm above the surgical target point until 2 mm below, resulting in 4 recording sites. Data from
26 nuclei from 14 patients were analysed. For each trajectory, we identiﬁed the recording site with the largest
spectral peak in the beta range (13–30 Hz), and the largest peak in the HFO range separately. In addition, we
identiﬁed the recording site with the largest beta-HFO PAC. Recording sites with largest beta power and largest
HFO power coincided in 50% of cases. In the other 50%, HFO was more likely to be detected at a more superior
recording site in the target area. PAC followed more closely the site with largest HFO (45%) than beta power
(27%). HFO are likely to arise from spatially close, but slightly more superior neural populations than beta
oscillations. Further work is necessary to determine whether the diﬀerent activities can help ﬁne-tune deep brain
stimulation targeting.
1. Introduction
The subthalamic nucleus (STN) is a prime target for deep brain
stimulation (DBS) for Parkinson's disease. Accurate positioning of
electrodes is essential for achieving optimal clinical outcome. Although
the STN is small in size, it is thought to consist of functional compart-
ments as deﬁned by their anatomical connections to limbic, associative,
or sensorimotor cortical and subcortical structures with varying degrees
of overlap (Parent and Hazrati, 1995; Lambert et al., 2012; Haynes and
Haber, 2013). Indeed, stimulation through electrode contacts placed in
the dorsolateral, or superolateral (sensorimotor) portion of the STN has
been found to be most eﬀective in reducing motor impairment (Lanotte
et al., 2002; Saint-Cyr et al., 2002; Godinho et al., 2006).
Local ﬁeld potentials recorded post-operatively from these DBS
electrodes have revealed that Parkinsonian bradykinesia and rigidity
are associated with excessive beta band oscillations (Gatev et al., 2006;
Hammond et al., 2007; Oswal et al., 2013). Both dopaminergic medi-
cation and DBS reduce beta band amplitude along with improvements
in clinical motor scores (Kühn et al., 2006, 2008, 2009; Weinberger
et al., 2006; Ray et al., 2008; Eusebio et al., 2011). In line with this, the
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sites where strongest beta band oscillations are recorded during elec-
trode implantation concur with the sites of any clinical stun eﬀect
(Chen et al., 2006), and often coincide with the positions of the DBS
contacts selected for chronic stimulation (Yoshida et al., 2010; Zaidel
et al., 2010).
Recently, high-frequency oscillations (HFO) within the 150–400 Hz
range have also been associated with the disease. HFO may show ab-
normally strong phase-amplitude coupling (PAC) with the beta band
that correlates with bradykinesia and rigidity UPDRS scores and is re-
duced with levodopa treatment (López-Azcárate et al., 2010; Özkurt
et al., 2011; van Wijk et al., 2016). Furthermore, its occurrence is in-
dicative of tremor (Hirschmann et al., 2016). This suggests that HFO
may be relevant for improving DBS targeting and treatment. At present,
little is known about the neuronal origin of HFO and whether it arises
from the same neural populations as beta oscillations.
In the current study, we explored whether beta band oscillations
and HFO can be localized to the same spatial location within the STN
area. This work complements earlier ﬁndings by Wang et al. (2014)
who found HFO to be localized towards the anterior part of STN using
intra-operative microelectrode recordings, and Yang et al. (2014) who
localized beta-HFO PAC in the superior part of the STN. Here we ex-
plicitly examined the localization of HFO with respect to beta band
oscillations to infer whether these can be considered to arise from dif-
ferent neural populations. This is particularly relevant for assessing the
potential contribution of HFO power and beta-HFO PAC as independent
data features for ﬁne-tuning DBS.
2. Methods
All patients in this study were diagnosed with Parkinson's disease
according to the Queen Square Brain Bank Criteria (Gibb and Lees,
1988), and underwent surgery at the National Hospital for Neurology
and Neurosurgery in London, UK. Intraoperative LFP recordings were
obtained from 26 subthalamic nuclei in 14 patients as part of the
clinical procedure to aid localization and were provided for analysis by
the clinical team in anonymised form. All patients gave their written
informed consent to the procedure including LFP recordings. Average
age of patients at the time of surgery was 59 years (range 51–65) with a
disease duration of 10 years (range 6–17) after diagnosis. Pre-operative
Uniﬁed Parkinson's Disease Rating Scale (UPDRS) part III scores (motor
section) on average totalled 46 points (range 28–72) oﬀ medication,
with an average sum of hemibody bradykinesia and rigidity items of 12
(range 6–22).
Using a T1 and T2-weighted MRI guided and MRI veriﬁed approach,
DBS electrodes were implanted bilaterally in the visualized STN as per
the centre's standard procedures (Foltynie et al., 2011). The intended
target for the lowermost contact of the DBS electrode (‘C0’) was de-
termined on a stereotactic axial T2-weighted MRI scan lying at the level
of the largest diameter of the nucleus ruber, which corresponds to the
ventral part of the STN (Hariz et al., 2003). The centre of the sub-
thalamic nucleus was identiﬁed in a plane 0–1 mm behind the anterior
border of the nucleus ruber (Bejjani et al., 2000). A double oblique
trajectory was planned to avoid sulci and ventricles. Surgery was per-
formed under local anaesthesia after overnight withdrawal of medica-
tion. During the LFP recordings, patients were awake and instructed to
keep eyes opened and rest without voluntary movement or speech.
Excluding the 4 hemispheres without a clear peak in the HFO range (see
below), the lowermost contact was eventually ﬁxed either at the target
point location (6 nuclei), 1 mm below (1 nucleus) or 2 mm below (15
nuclei), depending on observed beta activity in the LFP recordings and
the patient's response to intraoperative stimulation that took place after
the LFP recordings. A ﬁxation site of 2 mm below the surgical target
point was often chosen to ensure placement of at least two contacts
within the STN.
The DBS leads used for recordings were of model 3389, (Medtronic,
Minneapolis, MN, USA), and contained four cylindrical platinum-
iridium contacts with a length of 1.5 mm and a diameter of 1.27 mm
each and were separated by 0.5 mm. Hence the distance between the
centre of adjacent contacts was 2 mm. Monopolar recordings (with
linked ear reference) were examined but found to be contaminated by
high amplitude alpha activity. An oﬄine bipolar derivation between
adjacent contacts eliminated the alpha peak, which is therefore likely to
arise through volume conduction. This observation is in accordance
with recent experimental work demonstrating superior performance for
bipolar compared to monopolar macroelectrode recordings in detecting
beta oscillations within the STN (Marmor et al., 2017). We decided to
use only the derivation between the two lowermost contacts in this
study to limit a reduction in recorded signal induced by the tip of the
lead while sliding through the tissue (stun eﬀect). Local ﬁeld potentials
were typically recorded while advancing the leads in 2 mm steps from
4 mm above until 2 or 4 mm below the surgical target point within the
STN. For the majority of cases, this resulted in recordings from 4 sites
(+4, +2, 0, −2 mm, for 16 nuclei in 11 patients), while for 5 nuclei
(in 3 patients) we had recordings from 5 sites available (+4, +2, 0,
−2, −4 mm), and in 1 nucleus from 3 sites (+4, 0, −2 mm). This
sums up to 92 sampling points. For hemispheres not included in the
results (see later) we had either 4 (2 nuclei in 2 patients) or 5 (2 nuclei
in 2 patients) recording sites.
We localized all recordings sites in 3D using the Lead-DBS toolbox
(Horn and Kühn, 2015) version 1.5.1.2. This involved marking the
electrodes’ positions on immediate postoperative stereotactic axial T2-
weighted MRI images (voxel size 0.488 × 0.488 × 2 mm), co-regis-
tration with the pre-operative T1 scan, and (nonlinear) normalization to
MNI space (using DARTEL implemented in SPM12). This allowed us to
visualize recording sites of all patients together in one ﬁgure (Fig. 1).
Left-hemisphere electrodes were ﬂipped to the right hemisphere. We
used a 7 T-based atlas to outline the STN and substantia nigra (Wang
et al., 2016), and a histological atlas to outline thalamic structures
(Chakravarty et al., 2006) warped to the ICBM Nonlinear 2009b tem-
plate (Ewert et al., 2016). The bipolar recordings were visualized as a
single point midway between the location of the two lowermost
Fig. 1. Lateral view of all intra-operative recording sites across patients. Each black dot
represents the midpoint between the locations of the two lowermost contacts at each
recording site as we used a bipolar derivation. The actual volume from which activity was
picked up was much larger than a single point in space. The ﬁgure contains recordings
from both the right and left hemisphere (mirrored in the y-axis). A relatively wide spatial
range was sampled including sites inside the STN (shown in green), and sites where it was
more likely to pick up activity from the thalamus (blue) or substantia nigra (red). A total
of 92 points are depicted (all cases included in the study). The inserted axes indicate 1 cm
in each direction. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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contacts.
The average duration of a recording per site was 71 s (range
21–94 s). The earliest recordings were collected with a sampling rate of
1600 Hz (2 patients) or 1500 Hz (1 patient) before selecting a ﬁxed
sampling rate of 1024 Hz for the remainder of the cohort (11 patients).
A low-pass ﬁlter was set at half the sampling rate. All subsequent
analyses were performed using custom-written Matlab scripts (R2014a,
The Mathworks Inc., Natick, USA). We eliminated 50 Hz line noise ar-
tefacts and subsequent harmonics up to half the sampling rate using 4th
order Butterworth notch ﬁlters with cut-oﬀ frequencies of± 1 Hz
around the centre frequency. In addition, notch ﬁlters with the same
settings were used to remove sharp artefacts at other frequencies that
might have originated from other devices in the operating theatre.
These often occurred for multiple frequencies above 50 Hz without
being exact harmonics. They were easily identiﬁable by the sharpness
of their spectral peaks, which was similar to that of the 50 Hz harmo-
nics. By contrast, HFO peaks were much broader, spanning a range of
50 Hz or more.
For each nucleus, we compared absolute spectral power across sites
to identify the site with the largest beta peak and the site with the
largest HFO peak. Power spectral densities were computed using
Matlab's pwelch method with Hanning windows of 1 s duration and
50% overlap. Spectral dips due to the application of notch ﬁlters were
masked by removing power values for frequencies± 3 Hz around the
centre frequency and a subsequent linear interpolation of the missing
values. All maxima within the beta band interval (13–30 Hz) were de-
tected using the ﬁrst and second derivatives of the spectra. The max-
imum with the largest value was designated as the largest peak, and
was compared against those obtained from other recording sites. The
same procedure was followed for the detection of the largest HFO peak
(within 150–400 Hz), except that the power spectrum itself was ﬁrst
smoothed across frequencies (2nd order low-pass 0.1 Hz Butterworth
ﬁlter) and a linear slope was removed from the spectrum spanning
100–400 Hz, which was computed from the average power within the
100–110 Hz and 390–400 Hz intervals. This procedure is illustrated in
Fig. 2. A linear slope based on raw power more adequately captured
background activity in this frequency range than a slope based on log-
transformed power. The result of this automatic peak detection was
carefully examined by eye. In case a peak was identiﬁed that was
deemed not representative of the beta or HFO range, e.g. due to the 1/f-
like shape of the spectrum for low frequencies, the second or third
largest maximum was designated as the peak for that recording site.
This mainly aﬀected sites that were not selected as having maximum
beta or HFO power (beta: 4% of selected versus 15% of unselected sites;
HFO: 0% of selected versus 25% of unselected sites). Cases in which no
clear peak could be identiﬁed in the beta (n= 1) or HFO range (n= 4)
in any of the recording sites were excluded from the data, leaving 22
nuclei from 13 patients. Typically, a single peak dominated within the
beta and HFO range, while multiple peaks were rarely observed.
In addition to spectral power, we looked at beta-HFO phase-am-
plitude coupling and identiﬁed the site with the largest PAC per nu-
cleus. Here we opted for the average value across all beta and HFO
frequency combinations within the spectrum rather than the peak value
to reduce the inﬂuence of noisy outliers and to account for the spatial
extent of PAC across frequencies. For this we computed PAC values
using a general linear model (Penny et al., 2008; van Wijk et al., 2015).
Firstly, we obtained low- and high-frequency components of the LFP
signals by bandpass-ﬁltering around centre frequencies between 5 and
35 Hz with 1 Hz steps (ﬁlter bandwidth± 1 Hz), and between 150 and
400 Hz in steps of 2 Hz (ﬁlter bandwidth± 35 Hz). Subsequently we
extracted the instantaneous phase for each low-frequency component
via θx=mod(angle(hilbert(x)),2π), and amplitude of each high-fre-
quency component via ay=abs(hilbert(y)). We then formulated a
general linear model as: ay=β1sin(θx)+β2cos(θx) for each combina-
tion of low frequency components x and high frequency components y.
The β-coeﬃcients were estimated via least squares and combined to
yield a single PAC value per frequency combination: = +r β β1
2
2
2 .
PAC values were averaged within the beta (13–30 Hz) and HFO
(150–400 Hz) frequency intervals and the site with the largest average
was identiﬁed. In order to assess the signiﬁcance of PAC in individual
spectra, we divided the continuous time series into 3.5 s non-over-
lapping epochs and repeated the estimation of the β-coeﬃcients for
each epoch. We then used parametric statistics to compare the dis-
tribution of β-coeﬃcients across epochs against zero. See van Wijk et al.
(2015) for more details of this method. A Bonferroni correction was
applied to correct for the number of frequency combinations within the
PAC spectrum (α= 0.05 / 4410).
The number of nuclei was counted in which the sites with the largest
values for the diﬀerent measures coincided, and was expressed as a
percentage out of all nuclei. The expected number of observed nuclei
due to chance was computed by assuming an a priori uniform prob-
ability across sites for each measure independently. A binomial test was
then performed to compute the probability of ﬁnding the
Fig. 2. Peak detection in the HFO range. This ﬁgure illustrates the procedure we followed
for HFO peak detection applied to a case with pronounced 50 Hz harmonics. Firstly,
spectral values within 3 Hz around harmonics were removed and interpolated (A).
Secondly, the interpolated time series was low-pass ﬁltered and a linear slope spanning
the 100–400 Hz range was determined based on the average power within the
100–110 Hz and 390–400 Hz intervals shown in orange (B). The linear slope was then
subtracted from the smoothed curve and the maximum value of the resulting curve was
detected (C).
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experimentally observed number of nuclei. In addition, we looked at
the spatial distribution of locations with maximum beta/HFO power
and PAC. This was expressed relative to the surgical target point as well
as relative to the ﬁxation site, in order to predict the distribution across
contact pairs after implantation. We also tested for diﬀerences in MNI
coordinates between sites with maximum power or PAC using paired-
samples t-tests.
3. Results
Fig. 3 illustrates an example of estimated power and PAC spectra for
all recording sites in a single nucleus. Here, the largest beta band power
was observed at the same recoding site as the maximum HFO power.
This also coincided with the largest average beta-HFO PAC, which was
found to be signiﬁcant in this case. We found signiﬁcant PAC in at least
one of the recording sites in 15 nuclei (68% of cases). Table 1 lists for all
individual nuclei the peak frequencies of identiﬁed maximum power
and PAC and at which recording site they were found.
When considering all nuclei, we found an overlap in the electrode
track depth of maximum beta and HFO power in 50% of cases. The
probability of observing the largest value of two measures at the same
recording site due to chance alone equalled 0.247, meaning that the
chance of randomly observing 11 out of 22 cases was p= 0.009. The
overlap between beta power and PAC was found to be lower (59%,
p < 0.001) than for HFO power and PAC (68%, p < 0.001). In 45% of
cases largest beta power, HFO power, and PAC occurred at the same
recording site, which was considerably higher than the number of cases
expected by chance (p < 0.001). Remarkably, 91% of cases where
largest beta and HFO power was found at the same recording site also
had the largest PAC at this location, and PAC was found to be sig-
niﬁcant in all of them. Looking only at cases where largest beta and
HFO power were identiﬁed at diﬀerent locations, largest PAC was
identiﬁed at the same site as beta power in 27% of cases (p= 0.502)
and in 45% (p= 0.094) of cases at the same site as HFO power. These
results are visualized in Fig. 4.
An interesting pattern emerged when looking at the spatial dis-
tribution of beta/HFO power and PAC (Fig. 5A). While largest beta
power was most likely to occur at the surgical target point site, largest
HFO was detected most often at the ﬁrst recording site, 4 mm above the
target point, and increasingly less often for subsequent sites. This dis-
tribution however does not convey the relative location between
maximum sites within a nucleus. We therefore also express the sites
with largest power or PAC relative to one another in Fig. 5B. This
conﬁrmed the detection of largest HFO at more superior sites relative to
Fig. 3. Power spectral densities and phase-amplitude coupling for diﬀerent recordings sites in an example nucleus. Top row shows spectral power for frequencies around the beta band,
second row shows corrected power (low-pass ﬁltered and detrended) for the HFO frequency range. Peaks selected for comparison across sites are marked with an asterisk. PAC between
beta and HFO frequencies is shown in the third row where warmer colours indicate stronger coupling. The corresponding panels in the fourth row indicate for which frequency
combinations PAC was found to be signiﬁcant (in black) after applying a Bonferroni correction. In this example, largest beta power, HFO power, and PAC were all found at the same
recording site.
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beta power. A similar tendency could be observed for the relative dis-
tribution of beta power and PAC, but a more symmetric distribution
was found for PAC relative to HFO power. In order to determine which
contacts are expected to cover the locations with largest power or PAC
after lead implantation, we show in Fig. 5C the spatial distribution with
respect to the site where the lowermost contact was eventually ﬁxated
(often 2 mm below the target point). This revealed that largest HFO is
most likely to be found at 6 mm above the ﬁxation site, which corre-
sponds to a location not covered by the implanted lead as it would
require a derivation between the most proximal contact and another
one 2 mm above. Similarly, several sites with largest beta power are
also not covered. The sites with largest power or PAC that are covered
by the implanted lead are expected to be distributed approximately
equally across contacts.
Visualization of the 3D coordinates in the coronal plane made this
point even more clear (Fig. 6A). While largest beta power was found at
various depths within the STN, largest HFO power was detected more
often in the upper part and above. Indeed, coordinates of the sites with
largest beta power (average MNI coordinates = 12.12, –14.01,
−5.64 mm) were signiﬁcantly diﬀerent from the coordinates of largest
HFO power (12.46, –13.56,−4.32 mm) in x-direction (t(21) =−2.47,
p= 0.022), y-direction (t(21) =−2.38, p= 0.027) and z-direction (t
(21) =−2.72, p= 0.013). The coordinates for the sites with largest
PAC (12.31, –13.74, −4.86 mm) did not diﬀer from the sites with
largest beta or HFO power in any of the directions (p > 0.17). All peak
locations are presented in a single ﬁgure in panel 6B.
Despite more recordings with signiﬁcant PAC for nuclei in which
beta and HFO power were found at the same site compared to nuclei
without overlapping sites, the diﬀerence in average PAC did not reach
signiﬁcance (independent samples t-test, t(20) = 0.97, p= 0.345). Nor
was there a signiﬁcant diﬀerence in largest beta power or HFO power
between nuclei with and without overlapping beta and HFO sites (t(20)
= 0.89, p= 0.382; t(20) =−0.16, p= 0.876). Pre-operative con-
tralateral hemibody bradykinesia/rigidity UPDRS scores were similar as
well (t(20) =−0.87, p= 0.393). Hemibody bradykinesia/rigidity
UPDRS scores were also not found to be correlated across nuclei with
beta peak value (r= 0.27, p= 0.222), HFO peak value (r= 0.12,
p= 0.601), average PAC (r= 0.31, p= 0.167), beta peak frequency
(r=−0.07, p= 0.759) or HFO peak frequency (r=−0.16,
p= 0.473). Finally, we looked at correlations between peak values for
beta power, HFO power, and average PAC across the 10 nuclei for
which these features were localized to the same recording site. Only
beta power and PAC were found to be signiﬁcantly correlated
(r= 0.77, p= 0.009). No signiﬁcant correlation was found between
beta and HFO power (r=−0.22, p= 0.533), nor between HFO power
and PAC (r= 0.08, p= 0.823).
Table 1
Individual peak frequencies of identiﬁed recording sites with largest beta/HFO power and PAC. The frequency resolution for spectral power was 0.2 Hz. Nuclei for which PAC was found
to be signiﬁcant are indicated with an asterisk. Although we averaged PAC values across the spectrum in our main analyses, peak frequencies are listed here for comparison with spectral
peak frequencies.
Case Left hemisphere Right hemisphere
Beta peak
frequency
[Hz]
Recording
site [mm]
HFO peak
frequency
[Hz]
Recording
site [mm]
PAC peak
frequency
[Hz]
Recording
site [mm]
Beta peak
frequency
[Hz]
Recording
site [mm]
HFO peak
frequency
[Hz]
Recording
site [mm]
PAC peak
frequency
[Hz]
Recording
site [mm]
1 29.0 0 336.0 0 23/342* 0
2 17.2 +4 252.8 +4 21/218 0
3 16.8 0 225.6 +4 17/250* +4 16.8 0 231.8 +4 18/256* +4
4 13.4 +4 241.8 +2 15/274* +4 13.4 −2 244.2 +4 15/262* +4
5 19.4 +4 227.8 +4 19/234* +4 20.4 +4 231.2 +4 21/264* +4
6 16.0 +4 238.4 +4 16/254* +4 15.6 +4 236.6 +4 16/256* +4
7 14.6 −2 234.2 +2 20/352 +2 20.4 0 224.6 +2 30/196 −4
8 18.8 0 246.4 0 27/266* 0 19.8 0 251.0 0 18/272* 0
9 16.4 −2 224.2 +4 16/224 −2
10 25.0 0 248.6 +2 17/276 +2 25.2 +2 240.2 +4 22/312 0
11 17.4 +2 236.2 +2 18/252* +2
12 21.2 +2 244.0 +2 23/274* +2 20.6 0 339.8 −2 16/368* 0
13 14.2 −2 220.8 0 19/328 +4 23.0 +2 270.0 +2 17/374* +2
Fig. 4. Overlap in identiﬁed recordings sites with largest beta and
HFO power. The number of observed nuclei in which the largest
power and/or PAC was observed in the same or in a diﬀerent re-
cording site is indicated, and in addition expressed as a percentage
of the total number of cases. Observations were split in nuclei with
and without overlap in beta and HFO power and further examined
for overlap with largest PAC. Largest PAC was highly likely to be
found at the same recording site if there was an overlap between
beta and HFO power. For cases without overlap in beta and HFO
power, PAC tended to occur more often at the site of largest HFO
power than beta power. The number of nuclei in which PAC was
found to be signiﬁcant after applying a Bonferroni correction is
indicated in brackets.
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4. Discussion
Using intraoperative bipolar recordings of LFPs through DBS elec-
trode contacts, we identiﬁed the relative location of strongest beta band
oscillations, high-frequency oscillations, and beta-HFO phase-ampli-
tude coupling within the region of the subthalamic nucleus of
Parkinson's disease patients. Largest beta, HFO and PAC spectral peaks
were found at the same recording site in half of the nuclei investigated.
In nuclei without overlap in beta and HFO power, HFO tended to occur
at a more superior location than beta power. In these cases, the site with
strongest PAC was slightly more likely to be found at the site with
largest HFO, although numbers were too small to conﬁrm a statistical
relation. These ﬁndings contribute towards the neurophysiological in-
terpretation of HFO and beta-HFO PAC, and may serve as a foundation
for studies aiming to improve DBS targeting.
Previous studies have investigated the spatial distribution of beta
power (Kühn et al., 2005; Steigerwald et al., 2008; Zaidel et al., 2010;
Seifried et al., 2012), HFO power (Wang et al., 2014) and beta-HFO
PAC (Yang et al., 2014) in the subthalamic nucleus. All demonstrate
largest power/PAC values in the dorsolateral STN, around 2 mm below
its superior border. From these independent studies, it is unclear what
relative source locations are underlying these various data features.
Wang et al. (2014) identiﬁed the location of HFO to be deeper and more
anterior compared to the DBS target site. Given the correspondence
between the occurrence of beta oscillations and the location with lar-
gest clinical response (Chen et al., 2006; Yoshida et al., 2010; Zaidel
et al., 2010), this suggest that HFO might be located more ventral than
beta oscillations. The present study is the ﬁrst to directly compare the
relative location of beta and HFO power and beta-HFO PAC within the
same nucleus. Our ﬁndings indicate the same or even a more superior
location of HFO compared to beta power.
While most studies on oscillatory activity in Parkinson's disease
have focused on the beta band, relatively little is known about the
neuronal origins of HFO. It is thought to reﬂect activity independent
from neural spiking recorded in the signal (Wang et al., 2014; Yang
et al., 2014). Like gamma band activity (~60–90 Hz), the amplitude of
HFO increases with movement (Foﬀani et al., 2003; López-Azcárate
et al., 2010; Litvak et al., 2012; Tan et al., 2013). Several studies have
noted a shift in peak frequency upwards after administration of dopa-
minergic medication but report conﬂicting ﬁndings regarding the eﬀect
on amplitude, as well as on the relation between HFO amplitude and
UPDRS scores (López-Azcárate et al., 2010; Özkurt et al., 2011; Wang
et al., 2014; van Wijk et al., 2016). It also remains to be established
whether HFO directly relate to the bursting activity that is associated
with Parkinson's disease, where intraburst discharge rates might fall
within the HFO range (Wichmann and Soares, 2005; Gale et al., 2009;
Fig. 5. Spatial distribution of largest beta/HFO power and PAC
across recording sites. All plots show histograms with the
number of observations. Panel A depicts the distribution of re-
cording sites relative to the surgical target point. The relative
locations of largest power and PAC within nuclei are shown in
panel B. Although largest beta and HFO power occurred at the
same recording site in half of the nuclei, HFO tended to peak at
slightly more superior sites for the other nuclei. Panel C depicts
the distribution of recording sites relative to the ﬁxation site of
contact C0. The range spanned by the implanted lead is in-
dicated in the Figure. This reveals that several sites with largest
power or PAC are not covered by the lead after implantation. In
all cases, positive distances indicate more superior locations. For
nuclei with 5 recording sites available the relative distance be-
tween sites with maximum power or PAC did not exceed 6 mm.
The nucleus where contact C0 was ﬁxated at −1 mm was dis-
carded from the relative to ﬁxation site histogram.
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Sharott et al., 2014).
The presence of a spectral peak within the HFO frequency range
seems critical for signiﬁcant PAC to occur. Cases with signiﬁcant PAC
all had the largest HFO power peak present at the same recording site or
at least a discernible subpeak. The 4 nuclei we excluded from analysis
based on the lack of a clear peak within the HFO frequency range also
failed to show signiﬁcant PAC. There is a possibility that in these cases
electrodes were positioned in a suboptimal location for detecting HFO
or that HFO and PAC are more sensitive to stun eﬀects than beta ac-
tivity. While high beta and HFO power would improve the detectability
of PAC because of more reliable phase and amplitude estimates, PAC
did not blindly follow the site with largest beta power and was un-
correlated with HFO peak amplitude. Also beta and HFO peak ampli-
tudes were uncorrelated (r= 0.17; p= 0.093), suggesting that these
peaks did not merely occur by picking up more signal overall at certain
sites. Our observation that PAC tended to follow the site with a clear
HFO peak is in line with the study by Meloni et al. (2015) who com-
pared the occurrence of beta-HFO PAC between diﬀerent contact pairs
along the electrode lead.
Considering that the volume of the STN is roughly 6 × 8 × 9 mm
(Mavridis et al., 2013), it is almost inevitable that some of the im-
planted contacts are outside the STN. The spatial range covered by our
intraoperative recordings made during the electrode descent was even
larger and from the 3D visualizations it becomes clear that it is possible
that some of the identiﬁed peak locations might reﬂect thalamic ac-
tivity. This especially applies to the sites with largest HFO power, which
were found signiﬁcantly more superior than the sites with largest beta
power. Interestingly, a recent intraoperative study with combined LFP
and single unit recordings also observed HFO above the STN border
(Telkes et al., 2016).
A limitation in the study resides in problems inherent to DBS ima-
ging (Horn and Kühn, 2015). The application of neuroimaging methods
to localize DBS electrodes comes with issues that we tried to minimize
but that cannot be fully overcome. For instance, the linear
coregistration between post- and preoperative acquisitions does not
account for brainshift that may happen when opening the skull during
surgery. Having said that, we employ several steps to minimize CSF leak
and brain shift during surgery (Petersen et al., 2010) that result in
minimal shift of the STN (Hyam et al., 2015). In addition, to co-register
localizations into standard space across patients, nonlinear warps were
applied that can never be perfectly precise and introduce problems to
the ﬁeld of neuroimaging as a whole (e.g., Klein et al., 2009; Ashburner
and Friston, 2011). To minimize bias introduced by these methodolo-
gical limitations, our pipeline was specially designed for the task of DBS
electrode localizations and cross-validated for both postoperative MRI
and CT (Horn and Kühn, 2015). Moreover, the processing stream has
been applied and validated in numerous studies that involved large
cohorts of subjects (Horn et al., 2017a, 2017b, 2017c). Each of the
critical steps (co-registration, nonlinear normalization and electrode
localization) included a manual control step in which results were
critically reviewed by an expert. Additionally, ﬁnal results of the elec-
trode localization were reviewed by an expert neurosurgeon to ensure
consistency with the post-operative MRI image and the surgeon's re-
port. Still, a gold-standard (such as postmortem histology) is lacking
and the precision of the applied methods is not perfect. The root mean
square error may only be assumed to be of the same order of magnitude
of ~1.3 mm reported by Schönecker et al. (2009) who used a pre-
decessor of our current localization pipeline.
Furthermore, the bipolar derivation used in our analyses allowed for
a more accurate estimation of local electrophysiological activity
(Marmor et al., 2017) but introduces uncertainty regarding the con-
tribution of each of the two contacts to the signal, and therefore the
exact location of the beta/HFO source. This is somewhat resolved by
comparing amplitudes between adjacent recording sites. Unless both
contacts are located within the generation zone, the bipolar pair with
the largest amplitude can be assumed to be closest to the source. We did
not observe a clear diﬀerence in spatial extent of beta and HFO peaks.
Both peaks were often present across adjacent recording sites but
Fig. 6. Locations of identiﬁed sites with largest power or
PAC. Panel A shows the coronal plane for each measure
separately. Each white star represents the ﬁnding of a
single hemisphere. STN is outlined in green, thalamic
structures in blue, and the substantia nigra in red. Locations
with largest beta power signiﬁcantly diﬀerent from loca-
tions with largest HFO power in x-, y-, and z-direction.
Locations with largest PAC did not signiﬁcantly diﬀer from
either beta or HFO power. Panel B shows all peak locations
from a lateral view. Sites where largest beta power was
found are shown in dark purple, sites with largest HFO in
light purple, and sites where largest beta and HFO coin-
cided are indicated in yellow. Black circular outlines re-
present the sites where largest PAC was found.
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diminished in amplitude. The systematic diﬀerence in location between
beta and HFO peaks suggests that our ﬁndings are uninﬂuenced by
these factors.
We noticed a striking correspondence for both beta and HFO peak
frequencies between left and right nuclei of the same subject, which has
been observed before (de Solages et al., 2010). Still we have treated left
and right nuclei as independent samples in our analysis to increase our
sample size. For the majority of cases both sides were included in the
analysis, and subjects hence equally contributed to the results. The
identiﬁed recording sites with largest power or PAC seems a bit more
variable between hemispheres, as we observed 4 cases with identical
sites for power and PAC in left and right nuclei and 6 cases with dif-
ferent sites.
The positive correlation between beta-HFO PAC and UPDRS scores
for bradykinesia and rigidity has led studies to speculate that beta band
oscillations constrain pro-kinetic HFO activities, therefore hampering
movement (López-Azcárate et al., 2010; van Wijk et al., 2016). Given
the strong co-variation between beta-HFO PAC and beta band power,
this could mean that any causal relation between high levels of beta
oscillations and motor impairments may be mediated via beta-HFO PAC
(or at least the two are highly inter-related). If so, therapeutic inter-
ventions to reduce PAC or to stimulate HFO activity might both be
successful.
At present, the mechanisms of action of DBS remain under debate.
Both direct electrical eﬀects of stimulation and more indirect eﬀects on
neurotransmitter release may play a role in reducing clinical symptoms,
and stimulation acts on eﬀerent as well as aﬀerent projections
(Herrington et al., 2015; Udupa and Chen, 2015). Some studies even
found the most eﬀective site for stimulation to be located just above the
superior border, hence outside the STN (Lanotte et al., 2002; Voges
et al., 2002). Unfortunately, we do not have measures of clinical out-
come upon stimulation available for all recording sites, making a direct
comparison between the presence of beta/HFO power or PAC and eﬀect
of stimulation diﬃcult in the current study. It would be interesting to
see whether DBS is more eﬀective when stimulation is applied through
electrodes from which HFO and beta-HFO PAC could be recorded. If so,
these data features may provide additional guidance for surgical tar-
geting, and may also be useful for optimizing closed-loop stimulation
(Little et al., 2013), or for steering current with directional leads (Bour
et al., 2015).
The presented work provides an exploratory study in this direction.
The relatively coarse sampling with 2 mm steps is insuﬃcient to draw
conclusions about ﬁne spatial scales, but our ﬁndings indicate that the
generators of HFO are closely, but slightly more superiorly located to
those of beta oscillations. There is even still the possibility of multiple
generating sites for beta and HFO oscillations that are spatially close to
another. Future work would therefore beneﬁt from a more detailed
topographic mapping to resolve this. New developments in imaging
methods and visualization techniques will substantially aid this direc-
tion of research.
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